Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.
Mult Scler Relat Disord
; 42: 102108, 2020 Jul.
Article
in En
| MEDLINE
| ID: mdl-32339987
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Demyelinating Autoimmune Diseases, CNS
/
Myelin-Oligodendrocyte Glycoprotein
/
Alemtuzumab
/
Immunologic Factors
Type of study:
Diagnostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2020
Document type:
Article
Country of publication:
Netherlands